LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
 61.16 770.25 7321 8892 0.8233 0.8928
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 61.16 770.25 7034 8892 0.7911 0.8715
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 63.39 770.25 7848 9326 0.8415 0.9063
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 63.39 770.25 7393 9326 0.7927 0.8750
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 65.61 770.25 8089 9736 0.8308 0.9013
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 65.61 770.25 7656 9736 0.7864 0.8729
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 67.83 770.25 8323 10078 0.8258 0.8995
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 67.83 770.25 7968 10078 0.7906 0.8773
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 70.05 770.25 8625 10413 0.8282 0.9022
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 70.05 770.25 8291 10413 0.7962 0.8823
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 72.27 770.25 8984 10730 0.8372 0.9086
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 72.27 770.25 8637 10730 0.8049 0.8890
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 74.50 770.25 9347 10991 0.8504 0.9172
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 74.50 770.25 8864 10991 0.8064 0.8909
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 76.75 770.25 9624 11262 0.8545 0.9204
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 76.75 770.25 9153 11262 0.8127 0.8956
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 78.98 770.25 9964 11518 0.8651 0.9271
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 78.98 770.25 9487 11518 0.8237 0.9030
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 81.20 770.25 10210 11766 0.8677 0.9291
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 81.20 770.25 9746 11766 0.8283 0.9065
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 83.42 770.25 10501 12031 0.8728 0.9325
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 83.42 770.25 9941 12031 0.8262 0.9060
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 85.64 770.25 10883 12287 0.8857 0.9402
MN20160304_L02
E22
MCF 10A-H2B-mCherry Trametinib
0.001
 85.64 770.25 10328 12287 0.8405 0.9149
MN20160304_L02
N21
MCF 10A-H2B-mCherry Trametinib
0.001
 87.86 770.25 11275 12543 0.8989 0.9477
MN20160304_L02
E22